SPR Therapeutics
PrivateLast Round
M&A
Jul 16, 2026
Est. Valuation
$650M
Total Funding Raised
$108.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SPR Therapeutics is a medical device company that develops and commercializes non-opioid, minimally invasive peripheral nerve stimulation therapy platforms for the management of acute and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SPR Therapeutics Comparables
Compare SPR Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curonix | 85% | |
| Neuros Medical | 82% | |
| Cortex, Inc. | 81% |
SPR Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Jul 16, 2026 | ||||
| Series D Extension | Feb 1, 2024 | ||||
| Series D | Oct 18, 2021 | ||||
| Grant | Oct 2, 2018 | ||||
| Series C | Sep 12, 2017 | ||||
Convertible Debt | Aug 25, 2015 |
Key People
Founding team and executive leadership
SPR Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Serial Stage Venture Partners | Series D |
| SLR Capital Partners | Series D Extension |
| Ohio Third Frontier Commission | Debt |
| JumpStart Ventures | Series A, Pre Seed |
| Mutual Capital Partners | Series D, Series D Extension |
| U.S. Department of Defense | Grant |
| NDI Healthcare Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
$650M round led by Medtronic.
- Apr 20, 2026
Monthly visitors increased 52% MoM.
SPR Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access